Stanford Center for
Biomedical Ethics

Publications

SCBE members publish often in leading journals,  most recently including Science and Nature.   SCBE is also home to the editorial office of the American Journal of Bioethics (AJOB).

Articles

Allyse, M., Sayres, L. C., Goodspeed, T. A., & Cho, M. K. (2014). Attitudes towards non-invasive prenatal testing for aneuploidy among US adults of reproductive age. J Perinatol, 34(6), 429-434. doi: 10.1038/jp.2014.30

Caulfield, T., Evans, J., McGuire, A., McCabe, C., Bubela, T., Cook-Deegan, R., et al (2013). Reflections on the cost of "low-cost" whole genome sequencing: framing the health policy debate. PLoS Biol, 11(11), e1001699. doi: 10.1371/journal.pbio.1001699

Cho, M. K. (2014). Open-label extension studies: are they really research? Am J Bioeth, 14(4), 60-61. doi: 10.1080/15265161.2014.889958
Darling, K. W., Boyce, A. M., Cho, M. K., & Sankar, P. L. (2014). “What is the FDA Going to Think?”: Negotiating Values through Reflective and Strategic Category Work in Microbiome Science. Science, Technology & Human Values. doi: 10.1177/0162243914545405

Erickson, J. A., Kuzmich, L., Ormond, K. E., Gordon, E., Christman, M. F., Cho, M. K., & Levinson, D. F. (2014). Genetic testing of children for predisposition to mood disorders: anticipating the clinical issues. J Genet Couns, 23(4), 566-577. doi: 10.1007/s10897-014-9710-y

Ormond, K. E., & Cho, M. K. (2014). Translating personalized medicine using new genetic technologies in clinical practice: the ethical issues. Per Med, 11(2), 211-222. doi: 10.2217/pme.13.104

Sayres, L. C., Allyse, M., Goodspeed, T. A., & Cho, M. K. (2014). Demographic and Experiential Correlates of Public Attitudes Towards Cell-Free Fetal DNA Screening. J Genet Couns. doi: 10.1007/s10897-014-9704-9

NRC Committee on Ethical and Societal Implications of Advances in Militarily Significant Technologies That Are Rapidly Changing and Increasingly Globally Accessible (2014). Emerging and Readily Available Technologies and National Security: A Framework for Addressing Ethical, Legal, and Societal Issues. Washington (DC): National Academies Press.

Greely, H. T. (2013). Mindreading, Neuroscience, and the Law. In S. Morse & A. Roskies (Eds.), A Primer on Criminal Law and Neuroscience (pp. 120-149): Oxford Univ. Press.

Greely, H. T. (2014). Academic chimeras? Am J Bioeth, 14(2), 13-14. doi: 10.1080/15265161.2014.871920

Greely, H. T., & Cho, M. K. (2013). The Henrietta Lacks legacy grows. EMBO Rep, 14(10), 849. doi: 10.1038/embor.2013.148

Jones, O. D., Marois, R., Farah, M. J., & Greely, H. T. (2013). Law and neuroscience. J Neurosci, 33(45), 17624-17630. doi: 10.1523/JNEUROSCI.3254-13.2013

Kaye, D. H., & Greely, H. T. (2013). Brief of Genetics, Genomics and Forensic Science Researchers as Amici Curiae in Support of Neither Party. Jurimetrics, 54, 43-64.

Zettler, P. J., & Greely, H. T. (2014). The Strange Allure of State "Right-to-Try" Laws. JAMA Intern Med. doi: 10.1001/jamainternmed.2014.5767

Zettler, P. J., Sherkow, J. S., & Greely, H. T. (2014). 23andMe, the Food and Drug Administration, and the future of genetic testing. JAMA Intern Med, 174(4), 493-494. doi: 10.1001/jamainternmed.2013.14706

Bahm, S. M., Karkazis, K., & Magnus, D. (2013). A content analysis of posthumous sperm procurement protocols with considerations for developing an institutional policy. Fertil Steril, 100(3), 839-843. doi: 10.1016/j.fertnstert.2013.05.002

Jordan-Young, R. M., Sonksen, P. H., & Karkazis, K. (2014). Sex, health, and athletes. BMJ, 348, g2926. doi: 10.1136/bmj.g2926

Karkazis, K., & Jordan-Young, R. (2013). The Harrison Bergeron olympics. Am J Bioeth, 13(5), 66-69. doi: 10.1080/15265161.2013.776375

Karkazis, K., & Jordan-Young, R. (2014). The Trouble with Too Much T. New York Times, A21.

Ladd, J. M., Karkazis, K., & Magnus, D. (2013). Parental refusal of vaccination and transplantation listing decisions: a nationwide survey. Pediatr Transplant, 17(3), 244-250. doi: 10.1111/petr.12046

Miller, A. C., & Karkazis, K. (2013). Health beliefs and practices in an isolated polygamist community of southern Utah. J Relig Health, 52(2), 597-609. doi: 10.1007/s10943-012-9593-x

Tamar-Mattis, A., Baratz, A., Baratz Dalke, K., & Karkazis, K. (2013). Emotionally and cognitively informed consent for clinical care for differences of sex development. Psychology & Sexuality, 5(1), 44-55. doi: 10.1080/19419899.2013.831215

Caulfield, T., Evans, J., McGuire, A., McCabe, C., Bubela, T., Cook-Deegan, R., et al (2013). Reflections on the cost of "low-cost" whole genome sequencing: framing the health policy debate. PLoS Biol, 11(11), e1001699. doi: 10.1371/journal.pbio.1001699

Lee, S., Vernez, S., Ormond, K. E., & Granovetter, M. (2013). Attitudes towards Social Networking and Sharing Behaviors among Consumers of Direct-to-Consumer Personal Genomics. Journal of Personalized Medicine, 3(4), 275-287.

Lee, S. S.-J. (2014). Genetics and Racial Minorities. In B. Jennings (Ed.), Encyclopedia of Bioethics (4th ed.). New York: Macmillan Publishing.

Lee, S. S.-J. (2014). Direct-to-Consumer Genetic Testing. In J. Wright (Ed.), International Encyclopedia of Social and Behavior Sciences (2nd ed.).

Scott, C. T., Borgelt, E. L., & Lee, S. S. (2014). The time is ripe for an ethics of entrepreneurship. Nat Biotechnol, 32(4), 316-318. doi: 10.1038/nbt.2867

Shim, J. K., Darling, K. W., Lappe, M. D., Thomson, L. K., Lee, S. S., Hiatt, R. A., & Ackerman, S. L. (2014). Homogeneity and heterogeneity as situational properties: Producing – and moving beyond? – race in post-genomic science. Social Studies of Science. 44(4):579-99. doi: 10.1177/0306312714531522

 

Bahm, S. M., Karkazis, K., & Magnus, D. (2013). A content analysis of posthumous sperm procurement protocols with considerations for developing an institutional policy. Fertil Steril, 100(3), 839-843. doi: 10.1016/j.fertnstert.2013.05.002

Magnus, D., Parsi, K., & Sharp, R. (2014). AJOB 2.0: Taking bioethics to a new level. Am J Bioeth, 14(8), 1-2. doi: 10.1080/15265161.2014.936788

Magnus, D. C., Wilfond, B. S., & Caplan, A. L. (2014). Accepting brain death. N Engl J Med, 370(10), 891-894. doi: 10.1056/NEJMp1400930

Van Cleave, A. C., Roosen-Runge, M. U., Miller, A. B., Milner, L. C., Karkazis, K. A., & Magnus, D. C. (2014). Quality of communication in interpreted versus noninterpreted PICU family meetings. Crit Care Med, 42(6), 1507-1517. doi: 10.1097/CCM.0000000000000177

 

Olson, N. W. (2014). Conceptualizing ancillary care obligations in health systems research. Am J Bioeth, 14(2), 46-47. doi: 10.1080/15265161.2013.868959

Ashfaq, M., Amanullah, F., Ashfaq, A., & Ormond, K. E. (2013). The views of Pakistani doctors regarding genetic counseling services - is there a future? J Genet Couns, 22(6), 721-732. doi: 10.1007/s10897-013-9578-2

Daneshjou, R., Zappala, Z., Kukurba, K., Boyle, S. M., Ormond, K. E., Klein, T. E., et al (2014). PATH-SCAN: a reporting tool for identifying clinically actionable variants. Pac Symp Biocomput, 229-240.

Dewey, F. E., Grove, M. E., Pan, C., Goldstein, B. A., Bernstein, J. A., Chaib, H., et al (2014). Clinical interpretation and implications of whole-genome sequencing. JAMA, 311(10), 1035-1045. doi: 10.1001/jama.2014.1717

Erickson, J. A., Kuzmich, L., Ormond, K. E., Gordon, E., Christman, M. F., Cho, M. K., & Levinson, D. F. (2014). Genetic testing of children for predisposition to mood disorders: anticipating the clinical issues. J Genet Couns, 23(4), 566-577. doi: 10.1007/s10897-014-9710-y

Grove, M. E., Wolpert, M. N., Cho, M. K., Lee, S. S., & Ormond, K. E. (2014). Views of genetics health professionals on the return of genomic results. J Genet Couns, 23(4), 531-538. doi: 10.1007/s10897-013-9611-5

Hooker, G. W., Ormond, K. E., Sweet, K., & Biesecker, B. B. (2014). Teaching genomic counseling: preparing the genetic counseling workforce for the genomic era. J Genet Couns, 23(4), 445-451. doi: 10.1007/s10897-014-9689-4

Ormond, K. E. (2013). From genetic counseling to "genomic counseling". Mol Genet Genomic Med, 1(4), 189-193. doi: 10.1002/mgg3.45

Ormond, K. E., & Cho, M. K. (2014). Translating personalized medicine using new genetic technologies in clinical practice: the ethical issues. Per Med, 11(2), 211-222. doi: 10.2217/pme.13.104

Borgelt, E. L., Dharamsi, S., & Scott, C. T. (2013). Dear student: stem cell scientists' advice to the next generation. Cell Stem Cell, 12(6), 652-655. doi: 10.1016/j.stem.2013.05.007

Caulfield, T., Burningham, S., Joly, Y., Master, Z., Shabani, M., & al., e. (2014). A review of the key issues associated with the commercialization of biobanks. Journal of Law and the Biosciences, 1, 99-110.

Chang, W., Bank, T. C., & Scott, C. T. (2013). Fit to Print? Media Accounts of Unproven Medical Treatments Across Time. AJOB Empirical Bioethics, 5(1), 33-43. doi: 10.1080/21507716.2013.785988

Haimes, E., Skene, L., Ballantyne, A. J., Caulfield, T., Goldstein, L. S., Hyun, I., et al (2013). Position statement on the provision and procurement of human eggs for stem cell research. Cell Stem Cell, 12(3), 285-291. doi: 10.1016/j.stem.2013.02.002

Liu, E. Y., & Scott, C. T. (2014). Great expectations: autism spectrum disorder and induced pluripotent stem cell technologies. Stem Cell Rev, 10(2), 145-150. doi: 10.1007/s12015-014-9497-0

Scott, C. T. (2013). Advantage, Access, and Anticipation: The impacts of policy, ethics, law, and economics on stem cell research. (Doctoral), University of British Columbia, Vancouver, BC.

Sherkow, J. S., & Scott, C. (2014). Myriad stands alone. Nat Biotechnol, 32(7), 620. doi: 10.1038/nbt.2944

 

Last revised 10/9/14

Stanford Medicine Resources:

Footer Links: